Back to search
FDAFDA · Food and drugs·Recall number Z-1858-2014

NxStage Dialysate Sack (SAK) with Concentrate for Use with PureFlow SL REF: SAK-305 Lactate 45, Potassium 1, Sodium 140, Calcium 3, Magnesium 1 Chloride 100, Glucose (mg/dL) 100 Batch Size (liters) 40

Published July 2, 2014 · Recall initiated: May 14, 2014

Summary

FDA records medical device Class II recall Z-1858-2014, published July 2, 2014 and initiated May 14, 2014. Recalling firm: NxStage Medical, Inc.; Status: Terminated; Reported quantity: 2839 cases; Lot: Lot codes: 40179026 3057901 3047930. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

SAK Dialysate Concentrate contain aluminum levels which exceed internal product specification

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
NxStage Medical, Inc.
Distributor
Worldwide Distribution - USA (nationwide) and Internationally to France, Netherlands, Spain, Sweden, and the UK.
Lot
Lot codes: 40179026 3057901 3047930
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was NxStage Dialysate Sack (SAK) with Concentrate for Use with PureFlow SL REF: SAK-305 Lactate 45, Potassium 1, Sodium 140, Calcium 3, Magnesium 1 Chloride 100, Glucose (mg/dL) 100 Batch Size (liters) 40 recalled?

Yes. FDA published recall Z-1858-2014 on July 2, 2014. Reported hazard: SAK Dialysate Concentrate contain aluminum levels which exceed internal product specification

What should I do if I have this product?

Voluntary: Firm initiated · Letter